Evidence map›Paper›PMID 33308504›Full record

ReviewAdvances in chronic kidney disease2020

Policy and Pandemic: The Changing Practice of Nephrology During the Coronavirus Disease-2019 Outbreak.

Tiffany Truong, Michael Dittmar, Arshia Ghaffari, Eugene Lin

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Advances in chronic kidney disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Humoral Immune Response to COVID-19 Vaccination in Hemodialysis Patients: A Retrospective, Observational Case-Control Pilot Study.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2022
    Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Tiffany TruongDivision of Nephrology and Hypertension, Department of Medicine, University of Southern California, Los Angeles, CA; Department of Medicine, University of Southern California, Los Angeles, CA.
Michael DittmarDepartment of Medicine, University of Southern California, Los Angeles, CA.
Arshia GhaffariDivision of Nephrology and Hypertension, Department of Medicine, University of Southern California, Los Angeles, CA; Department of Medicine, University of Southern California, Los Angeles, CA.
Eugene LinDivision of Nephrology and Hypertension, Department of Medicine, University of Southern California, Los Angeles, CA; Department of Medicine, University of Southern California, Los Angeles, CA; Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, CA; Kidney Research Center, University of Southern California/University Kidney Research Organization, Los Angeles, CA. Electronic address: eugeneli@usc.edu.
University of Southern California · US

Funding

Investigating the Economic and SocialDeterminants of Home Dialysis Drop-OutK08DK118213 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LIN, EUGENE · 2018 to 2022
$854k
NIDDK NIH HHS K08 DK118213
6 · The paper itself

Abstract

The coronavirus (coronavirus disease-2019) pandemic has changed care delivery for patients with end-stage kidney disease. We explore the US healthcare system as it pertains to dialysis care, including existing policies, modifications implemented in response to the coronavirus disease-2019 crisis, and possible next steps for policy makers and nephrologists. This includes policies related to resource management, use of telemedicine, prioritization of dialysis access procedures, expansion of home dialysis modalities, administrative duties, and quality assessment. The government has already established policies that have instated some flexibilities to help providers focus their response to the crisis. However, future policy during and after the coronavirus disease-2019 pandemic can bolster our ability to optimize care for patients with end-stage kidney disease. Key themes in this perspective are the importance of policy flexibility, clear strategies for emergency preparedness, and robust health systems that maximize accessibility and patient autonomy.

Indexed as

COVID-19Health PolicyNephrologyAmbulatory Care FacilitiesAnastomosis, SurgicalArteriesBlood Vessel Prosthesis ImplantationCenters for Medicare and Medicaid Services, U.S.Computer SecurityDelivery of Health CareDisaster PlanningHealth Services AccessibilityHemodialysis, HomeHemodialysis SolutionsHumansKidney Failure, ChronicHemodialysis SolutionsCoronavirusDialysisEnd-stage kidney diseasePolicy

Identifiers

PMID33308504
PMCPMC7311906
OpenAlexW3036987516

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.